RGEN REPLIGEN CORP
Nasdaq · SEC CIK 730272 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $11.77M 11 sales by 5 insiders
- Filings on record
- 208 since 2021-07-15, latest 2026-09-22 16:07
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Hunt Anthony | Dir | — | $7.01M |
| Loeillot Olivier | CEO, Dir | — | $4.19M |
| Bylund James | COO | — | $331.3K |
| Garland Jason K | CFO | — | $185.8K |
| DAWES KAREN A | Dir | — | $44.3K |
| Douglass Brian Robb | Chief PRODUCT Off | — | — |
| Pax Margaret | Dir | — | — |
| Hughes Violetta | CAO | — | — |
| Mhatre Rohin | Dir | — | — |
| Konstantinov Konstantin | Dir | — | — |
Transactions 266
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-07-22 | 2022-07-21 | RGEN | Hunt Anthony | CEO, Dir | S - Sale+OE | $200.00 | -24.8K | 194.7K | -11% | -$4.96M |
| D | 2022-05-31 | 2022-05-26 | RGEN | Mhatre Rohin | Dir | A - Grant | $0.00 | +1,202 | 1,659 | +263% | $0 |
| D | 2022-05-31 | 2022-05-26 | RGEN | MUIR GLENN P | Dir | A - Grant | $0.00 | +534 | 6,896 | +8% | $0 |
| D | 2022-05-31 | 2022-05-26 | RGEN | EGLINTON MANNER CARRIE | Dir | A - Grant | $0.00 | +1,024 | 1,481 | +224% | $0 |
| D | 2022-05-31 | 2022-05-26 | RGEN | Konstantinov Konstantin | Dir | A - Grant | $0.00 | +534 | 534 | New | $0 |
| D | 2022-05-31 | 2022-05-26 | RGEN | BARTHELEMY NICOLAS | Dir | A - Grant | $0.00 | +534 | 2,081 | +35% | $0 |
| D | 2022-05-31 | 2022-05-26 | RGEN | DAWES KAREN A | Dir | A - Grant | $0.00 | +644 | 77.2K | +0.8% | $0 |
| M | 2022-05-26 | 2022-05-25 | RGEN | DAWES KAREN A | Dir | S - Sale | $150.51 | -14.7K | 81.0K | -15% | -$2.21M |
| 2022-05-17 | 2022-05-13 | RGEN | Gebski Christine | See Remarks | F - Tax | $150.40 | -335 | 34.1K | -1.0% | -$50.4K | |
| 2022-05-17 | 2022-05-13 | RGEN | Snodgres Jon | CFO | F - Tax | $150.40 | -712 | 39.2K | -2% | -$107.1K | |
| 2022-05-17 | 2022-05-13 | RGEN | KURIYEL RALF | Senior VP, R, D | F - Tax | $150.40 | -712 | 20.1K | -3% | -$107.1K | |
| 2022-04-04 | 2022-04-01 | RGEN | Bylund James | COO | F - Tax | $188.02 | -335 | 9,733 | -3% | -$63.0K | |
| DM | 2022-03-09 | 2022-03-08 | RGEN | Snodgres Jon | CFO | M - OptEx | $41.34 | +4,166 | 38.7K | +12% | +$172.2K |
| 2022-03-03 | 2022-03-01 | RGEN | Hunt Anthony | CEO, Dir | F - Tax | $194.06 | -7,292 | 199.3K | -4% | -$1.42M | |
| M | 2022-03-02 | 2022-02-27+ | RGEN | Gebski Christine | See Remarks | F - Tax | $196.70 | -1,060 | 34.4K | -3% | -$208.5K |
| 2022-03-02 | 2022-02-28 | RGEN | Hunt Anthony | CEO, Dir | A - Grant | $0.00 | +30.1K | 220.0K | +16% | $0 | |
| M | 2022-03-02 | 2022-02-27+ | RGEN | Hunt Anthony | CEO, Dir | F - Tax | $196.70 | -19.3K | 193.1K | -9% | -$3.79M |
| M | 2022-03-02 | 2022-02-27+ | RGEN | KURIYEL RALF | Senior VP, R, D | F - Tax | $196.70 | -2,534 | 18.6K | -12% | -$498.4K |
| 2022-03-02 | 2022-02-28 | RGEN | KURIYEL RALF | Senior VP, R, D | A - Grant | $0.00 | +4,234 | 22.4K | +23% | $0 | |
| M | 2022-03-02 | 2022-02-27+ | RGEN | Snodgres Jon | CFO | F - Tax | $196.70 | -3,824 | 32.3K | -11% | -$752.2K |
| 2022-03-02 | 2022-02-28 | RGEN | Snodgres Jon | CFO | A - Grant | $0.00 | +5,922 | 38.2K | +18% | $0 | |
| D | 2022-03-02 | 2022-03-01 | RGEN | RYAN THOMAS F JR | Dir | M - OptEx | $38.76 | +1,000 | 3,457 | +41% | +$38.8K |
| DM | 2022-03-02 | 2022-03-01 | RGEN | RYAN THOMAS F JR | Dir | S - Sale+OE | $198.03 | -2,000 | 1,457 | -58% | -$396.1K |
| D | 2022-02-28 | 2022-02-24 | RGEN | KURIYEL RALF | Senior VP, R, D | A - Grant | $0.00 | +2,126 | 19.3K | +12% | $0 |
| D | 2022-02-28 | 2022-02-24 | RGEN | KURIYEL RALF | Senior VP, R, D | F - Tax | $189.21 | -188 | 19.1K | -1.0% | -$35.6K |
| D | 2022-02-28 | 2022-02-24 | RGEN | Bylund James | COO | A - Grant | $0.00 | +3,366 | 10.3K | +49% | $0 |
| D | 2022-02-28 | 2022-02-24 | RGEN | Bylund James | COO | F - Tax | $189.21 | -188 | 10.1K | -2% | -$35.6K |
| D | 2022-02-28 | 2022-02-24 | RGEN | Snodgres Jon | CFO | F - Tax | $189.21 | -269 | 33.6K | -0.8% | -$50.9K |
| D | 2022-02-28 | 2022-02-24 | RGEN | Snodgres Jon | CFO | A - Grant | $0.00 | +3,443 | 33.9K | +11% | $0 |
| D | 2022-02-28 | 2022-02-24 | RGEN | Gebski Christine | See Remarks | F - Tax | $189.21 | -181 | 35.5K | -0.5% | -$34.2K |
| D | 2022-02-28 | 2022-02-24 | RGEN | Gebski Christine | See Remarks | A - Grant | $0.00 | +2,124 | 35.7K | +6% | $0 |
| D | 2022-02-28 | 2022-02-24 | RGEN | Hunt Anthony | CEO, Dir | F - Tax | $189.21 | -1,170 | 195.8K | -0.6% | -$221.4K |
| D | 2022-02-28 | 2022-02-24 | RGEN | Hunt Anthony | CEO, Dir | A - Grant | $0.00 | +15.9K | 197.0K | +9% | $0 |
| 2022-02-22 | 2022-02-17 | RGEN | Snodgres Jon | CFO | A - Grant | $0.00 | +900 | 30.8K | +3% | $0 | |
| 2022-02-22 | 2022-02-17 | RGEN | Snodgres Jon | CFO | F - Tax | $182.42 | -332 | 30.5K | -1% | -$60.6K | |
| 2022-02-22 | 2022-02-17 | RGEN | KURIYEL RALF | Senior VP, R, D | A - Grant | $0.00 | +450 | 17.4K | +3% | $0 | |
| 2022-02-22 | 2022-02-17 | RGEN | KURIYEL RALF | Senior VP, R, D | F - Tax | $182.42 | -175 | 17.2K | -1% | -$31.9K | |
| 2022-02-22 | 2022-02-17 | RGEN | Bylund James | COO | F - Tax | $182.42 | -334 | 6,890 | -5% | -$60.9K | |
| 2022-02-22 | 2022-02-17 | RGEN | Bylund James | COO | A - Grant | $0.00 | +900 | 7,224 | +14% | $0 | |
| 2022-02-22 | 2022-02-17 | RGEN | Gebski Christine | See Remarks | A - Grant | $0.00 | +450 | 33.8K | +1% | $0 | |
| 2022-02-22 | 2022-02-17 | RGEN | Gebski Christine | See Remarks | F - Tax | $182.42 | -224 | 33.5K | -0.7% | -$40.9K | |
| 2021-12-15 | 2021-12-14 | RGEN | KURIYEL RALF | Senior VP, R, D | F - Tax | $252.53 | -445 | 16.9K | -3% | -$112.4K | |
| DM | 2021-11-19 | 2021-11-18 | RGEN | Hunt Anthony | CEO, Dir | S - Sale+OE | $276.85 | -17.4K | 183.7K | -9% | -$4.80M |
| D | 2021-11-19 | 2021-11-18 | RGEN | Hunt Anthony | CEO, Dir | M - OptEx | $32.40 | -10.0K | 199.5K | -5% | -$324.0K |
| DM | 2021-11-12 | 2021-11-10 | RGEN | DAWES KAREN A | Dir | S - Sale+OE | $263.93 | -4,783 | 91.3K | -5% | -$1.26M |
| D | 2021-11-12 | 2021-11-10 | RGEN | DAWES KAREN A | Dir | M - OptEx | $26.12 | -4,783 | 96.0K | -5% | -$124.9K |
| M | 2021-11-04 | 2021-11-02 | RGEN | DAWES KAREN A | Dir | S - Sale | $303.94 | -2,400 | 92.9K | -3% | -$729.5K |
| DM | 2021-11-04 | 2021-11-02+ | RGEN | RYAN THOMAS F JR | Dir | S - Sale+OE | $295.87 | +285 | 13.3K | +2% | +$84.3K |
| D | 2021-11-04 | 2021-11-02 | RGEN | RYAN THOMAS F JR | Dir | M - OptEx | $128.18 | +1,285 | 14.6K | +10% | +$164.7K |
| DM | 2021-11-02 | 2021-10-29 | RGEN | BARTHELEMY NICOLAS | Dir | S - Sale+OE | $288.20 | -1,645 | 1,907 | -46% | -$474.1K |
| D | 2021-11-02 | 2021-10-29 | RGEN | BARTHELEMY NICOLAS | Dir | M - OptEx | $128.18 | +1,285 | 3,192 | +67% | +$164.7K |
| M | 2021-09-15 | 2021-09-14 | RGEN | DAWES KAREN A | Dir | S - Sale | $294.26 | -274 | 93.8K | -0.3% | -$80.6K |
| DM | 2021-09-13 | 2021-09-09 | RGEN | Hunt Anthony | CEO, Dir | S - Sale+OE | $294.75 | -25.0K | 189.5K | -12% | -$7.37M |
| D | 2021-09-13 | 2021-09-09 | RGEN | Hunt Anthony | CEO, Dir | M - OptEx | $32.40 | +25.0K | 214.5K | +13% | +$810.0K |
| 2021-09-02 | 2021-09-01 | RGEN | Gebski Christine | See Remarks | S - Sale | $285.33 | -3,377 | 33.3K | -9% | -$963.6K | |
| 2021-09-02 | 2021-08-30 | RGEN | KURIYEL RALF | Senior VP, R, D | S - Sale | $282.13 | -4,001 | 17.4K | -19% | -$1.13M | |
| D | 2021-09-02 | 2021-09-01 | RGEN | DAWES KAREN A | Dir | M - OptEx | $38.76 | -3,459 | 97.4K | -3% | -$134.1K |
| DM | 2021-09-02 | 2021-09-01 | RGEN | DAWES KAREN A | Dir | S - Sale+OE | $283.91 | -3,459 | 94.8K | -4% | -$982.1K |
| M | 2021-08-19 | 2021-08-17+ | RGEN | DAWES KAREN A | Dir | S - Sale | $254.18 | -18.9K | 95.4K | -17% | -$4.80M |
| 2021-08-18 | 2021-08-17 | RGEN | Hunt Anthony | CEO, Dir | G - Gift | $0.00 | -1,000 | 189.5K | -0.5% | $0 | |
| 2021-08-05 | 2021-08-04 | RGEN | RYAN THOMAS F JR | Dir | S - Sale | $250.50 | -780 | 971 | -45% | -$195.4K | |
| DMA | 2021-07-22 | 2021-07-13 | RGEN | DAWES KAREN A | Dir | S - Sale+OE | $202.23 | -1,520 | 117.5K | -1% | -$307.4K |
| DA | 2021-07-22 | 2021-07-13 | RGEN | DAWES KAREN A | Dir | M - OptEx | $41.19 | +2,929 | 119.0K | +3% | +$120.6K |
| M | 2021-07-22 | 2021-07-20 | RGEN | DAWES KAREN A | Dir | S - Sale | $202.09 | -4,585 | 112.9K | -4% | -$926.6K |
| D | 2021-07-15 | 2021-07-13 | RGEN | DAWES KAREN A | Dir | S - Sale+OE | $202.23 | +1,520 | 117.5K | +1% | +$307.4K |
| D | 2021-07-15 | 2021-07-13 | RGEN | DAWES KAREN A | Dir | M - OptEx | $41.19 | +2,929 | 119.0K | +3% | +$120.6K |
Purchase Sale Sale after option exercise All abbreviations